Glenmark Pharmaceuticals gains as its arm launches Axitinib Tablets
Mumbai, November 16 (Udaipur Kiran): Glenmark Pharmaceuticals is currently trading at Rs. 2663.00, up by 20.00 points or 0.76% from its previous closing of Rs. 2643.00 on the…
Mumbai, November 16 (Udaipur Kiran): Glenmark Pharmaceuticals is currently trading at Rs. 2663.00, up by 20.00 points or 0.76% from its previous closing of Rs. 2643.00 on the…
Mumbai, October 6 (Udaipur Kiran): Glenmark Pharmaceuticals is currently trading at Rs. 2286.65, up by 5.05 points or 0.22% from its previous…
Mumbai, February 27 (Udaipur Kiran): Glenmark Pharmaceuticals is currently trading at Rs. 2134.75, up by 7.60 points or 0.36% from its previous…
Glenmark Pharmaceuticals is currently trading at Rs. 426.30, up by 0.50 points or 0.12% from its previous closing of Rs. 425.80 on…
Glenmark Pharmaceuticals is currently trading at Rs. 421.00, up by 4.55 points or 1.09% from its previous closing of Rs. 416.45 on…
Glenmark Pharmaceuticals is currently trading at Rs. 415.50, up by 6.30 points or 1.54% from its previous closing of Rs. 409.20 on…
Glenmark Pharmaceuticals is currently trading at Rs. 418.30, up by 5.10 points or 1.23% from its previous closing of Rs. 404.40 on…
Glenmark Pharmaceuticals is currently trading at Rs. 413.00, up by 8.60 points or 2.13% from its previous closing of Rs. 404.40 on…
Glenmark Pharmaceuticals is currently trading at Rs. 398.00, up by 2.60 points or 0.66% from its previous closing of Rs. 395.40 on…
Glenmark Pharmaceuticals has become the first Pharmaceutical Company to launch Thiazolidinedione Lobeglitazone (Lobeglitazone) in India for the treatment of type 2 diabetes…